安进Amgen Inc. (AMGN) 2009年年度报告「NASDAQ」.pdf

1、Amgen 2009 Annual Report and Financial SummaryAmgen Inc.One Amgen Center DriveThousand Oaks,CA 91320-About Amgen2010 Amgen Inc.All rights reserved.MC45347-AAmgen discovers,develops,manufactures,and delivers innovative human therapeutics.A biotechnology pioneer since 1980,Amgen was one of the first c

2、ompanies to realize the new sciences promise by bringing safe and effective medicines from the lab to the manufacturing plant to patients.Amgen therapeutics have changed the practice of medicine,helping millions of people around the world in the fi ght against serious illnesses.So far,more than 18 m

3、illion patients worldwide have been treated with Amgen products.With a broad and deep pipeline of potential new medicines,Amgen remains committed to advancing science to dramatically improve peoples lives.95437_Cvr_sprds.indd 195437_Cvr_sprds.indd 13/4/10 1:29 PM3/4/10 1:29 PMServing Patients for 30

4、 YearsSince 1980,Amgen has been a pioneer,leader,and innovator in medical biotechnology.Amgen medicines have helped more than 18 million people around the world fi ght cancer,kidney disease,rheumatoid arthritis,and other serious illnesses.With a number of novel potential new medicines in our pipelin

5、e,the next decade will mark a promising new chapter for Amgenand for patients.We are conducting medical research and clinical trials in our current therapeutic areas,and branching out into new areas where fresh treatment approaches are urgently neededareas such as bone health,cardiovascular disease,

6、cholesterol management,diabetes,and asthma.These are persistent and diffi cult medical issues that seriously impact the lives of growing numbers of patients around the globe.Biotechnology medicine plays an ever greater role in improving the lives of people everywhere,and Amgen continues to lead the